Geriatric Medicine Market

Geriatric Medicines Market: (Therapeutic Category: Analgesic, Antihypertensive, Statins, Antidiabetic, Proton Pump Inhibitor, Anticoagulant, Antipsychotic and antidepressant and Others; Conditions: Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory and Others, Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023

  • Rep Id : TMRGL2445
  • Published On : Mar 2018
  • No. of Pages : 86
  • Category : Healthcare


1. Preface
    1.1. Report Description
    1.2. Market Segmentation
    1.3. Research Methodology

2. Executive Summary    
    2.1. Global Geriatric Medicines Market, by Geography, 2014 & 2023 (Value %)
    2.2. Global Geriatric Medicines Market, by Therapeutic Category, 2014 (US$ Mn)
    2.3. Geriatric Medicines Market Snapshot

3. Global Geriatric Medicines Market – Industry Analysis
    3.1. Introduction
    3.2. Market Drivers
          3.2.1. Rise in Chronis Diseases
          3.2.2. Increase in Government support
    3.3. Restraints
          3.3.1. Lack of Patient Participation in Clinical Trials 
    3.4. Opportunity
          3.4.1. Asia Pacific Holds Immense Potential for Geriatric Medicines
    3.5. Pipeline Analysis (Phase III Drug Candidate)
    3.6. Market Attractiveness Analysis– Geriatric Medicines Market, by Geography (2014) (%)
    3.7. Heat Map Analysis, by Key Players, 2014

4. Market Segmentation – By Therapeutic Category
    4.1. Introduction
    4.2. Global Geriatric Medicines Market Revenue, by Therapeutic Category, 2013–2023 (US$ Mn)
    4.3. Global Analgesic Market Revenue, 2013–2023 (US$ Mn)
    4.4. Global Antihypertensive Market Revenue, 2013–2023 (US$ Mn)
    4.5. Global Statins Market Revenue, 2013–2023 (US$ Mn)
    4.6. Global Antidiabetic Market Revenue, 2013–2023 (US$ Mn)
    4.7. Global PPI Market Revenue, 2013–2023 (US$ Mn)
    4.8. Global Anticoagulant Market Revenue, 2013–2023 (US$ Mn)
    4.9. Global Antipsychotic Market Revenue, 2013–2023 (US$ Mn)
    4.10. Global Others Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation – By Condition
    5.1. Introduction 
    5.2. Global Geriatric Medicines Market Revenue, by Condition, 2013–2023 (US$ Mn)
    5.3. Global Cardiovascular Market Revenue, 2013–2023 (US$ Mn)
    5.4. Global Arthritis Market Revenue, 2013–2023 (US$ Mn)
    5.5. Global Neurological Market Revenue, 2013–2023 (US$ Mn) 
    5.6. Global Cancer Market Revenue, 2013–2023 (US$ Mn)
    5.7. Global Osteoporosis Market Revenue, 2013–2023 (US$ Mn)
    5.8. Global Respiratory Market Revenue, 2013–2023 (US$ Mn)
    5.9. Global Others Market Revenue, 2013–2023 (US$ Mn)

6.  Market Segmentation – By Geography
    6.1. Introduction
    6.2. Global Geriatric Medicines Market Revenue, by Geography, 2013–2023 (US$ Mn)
    6.3. North America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
    6.4. Europe Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
    6.5. Asia Pacific Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
    6.6. Latin America Geriatric Medicines Market Revenue, by Country, 2013–2023 (US$ Mn)
    6.7. MEA Geriatric Medicines Market Revenue, by Country, 2013–2023,0020(US$ Mn)

7. Recommendations

8. Company Profiles
    8.1. Abbott Laboratories, Inc.
    8.2. AstraZeneca plc
    8.3. Boehringer Ingelheim GmbH
    8.4. Bristol-Myers Squibb Company
    8.5. Eli Lilly and Company
    8.6. GlaxoSmithKline Plc.
    8.7. Merck & Company Inc.
    8.8. Novartis AG
    8.9. Pfizer, Inc.
    8.10. Sanofi S.A